The Wrong Passport

EVERY MEDICINE sold in Britain comes with what amounts to a product passport. The Summary of Product Characteristics tells prescribers what it contains, how much to take and which other medicines it must not be taken with. The leaflet in the packet tells patients the same. It is comprehensive, standardised and free to read.

It is also, on its own, not enough.

Triludan, the brand name for terfenadine, was one of the first hay fever tablets that did not cause drowsiness, and for years it was sold over the pharmacy counter. It was approved, effective and, taken as directed, safe for most people. It was also dangerous in the wrong company. Taken with certain antibiotics or antifungal medicines, which stop the body breaking the drug down, it could cause a fatal disturbance of heart rhythm. Grapefruit juice, it emerged, could do the same.

The danger was known, and the warnings were on the packet and in the prescribing information. However, some still took the combinations anyway. In 1997 the Department of Health moved Triludan back to prescription only, citing “continuing reports of serious heart rhythm disorders when terfenadine is incorrectly used, despite warnings and precautions”. America’s regulator reached the same conclusion that even careful prescribing and dispensing could not eliminate the risks.

Construction is now writing its own label.  And it risks a similar problem.

A better label

The EU’s revised Construction Products Regulation has applied since January 2026. It establishes a framework for digital product passports linking products to declared performance, conformity documents, instructions and safety information.

Better product information is intended to make misleading claims easier to challenge and failures easier to trace. Structured data should help designers compare products, make environmental reporting possible at scale and rewards manufacturers who invest in real performance data over those who invest in optimistic marketing.

It’s intended that passports become compulsory 18 months after the European Commission switches them on, which is most likely next year and thus unlikely to kick-in until 2029.

However, the UK is slightly behind. The Construction Products Reform White Paper of February 2026 commits to digital product records and a construction library developed with industry, but neither is yet law.

The golden thread, e.g. digital record of safety information that the Building Safety Act 2022 requires, covers the building rather than the products in it. Equally, a product passport is not an approval to use that product in a particular building. In fact, the danger is treating it as one.

 

What the label cannot see

Grenfell is a sobering reminder of many things, not least what product information can and can’t do. The Inquiry found that the fire performance claimed for the cladding panels and insulation had been misrepresented, that unfavourable test results had been withheld and that certification had failed to catch it. A passport filled in from those claims may potentially still have repeated them, reinforcing the need for reliable testing, access to the evidence, verification and enforcement.

But the Inquiry also found a second failure. “Everyone involved in the choice of the materials to be used in the external wall thought that responsibility for their suitability and safety lay with someone else.” In fact, the Building Regs already required the external walls to resist the spread of fire. That failure calls for something else: competent review, clear responsibility and control of change.

A passport describes a product as it was tested, not installed. Buildings get built with substitutions, variations and site tolerances, under programme pressure, by people who need the answer to be yes. The danger is that the passport, on its own, cannot see the difference.

Where a product or system has not been tested in the form proposed (Approved Document B) the government’s guidance on fire safety, allows an assessment based on sufficient relevant test evidence. It also warns that assessments “should not be regarded as a way to avoid a test where one is necessary”. The catch is that the assessment is often commissioned and paid for by the party that needs it to pass. As Ian Abley puts it, “An assessment fee should not guarantee a ‘yes’.”

When information is not enough

The natural response is to put more into the record: how a product should be installed, what it can be combined with and where it should not be used. The EU regulation already provides for much of this, including instructions for installation and connection, compatibility with other products and integration into kits and systems. But what no record can establish by itself is whether the evidence covers the particular assembly being designed, swapped in or built.

Medicine offers a cautionary lesson. A 2006 review showed that once interaction checks were built into prescribing software, clinicians overrode most drug safety alerts, between half and nearly all depending on the study, often with good reason: many warnings did not matter. A warning that fires on everything is read as a warning about nothing.

The second caution is that a manufacturer can identify tested configurations, known incompatibilities and limits of application. But it cannot vouch for every combination with products it has never tested, fixed by contractors it has never met. Asked to, it is likely to result in a long list of disclaimers.

The passport will make product information easier to find and compare. But whether that becomes knowledge depends on who reads it, whether they are competent to judge it, and whether they answer for what they conclude. Deciding that the evidence covers the assembly takes competent judgement, a recorded basis for acceptance and clear responsibility when the design changes.

Three tests

These principles point to at least three tests:

  1. What stands behind each claim? A passport could show whether a stated performance comes from a test, an assessment or a manufacturer’s declaration, and who signed it. Adding that field costs little. Making the evidence behind it accessible and reliable costs more, and matters more. The Manufacturers’ Information Hub, founded by Alex Small with Su Butcher among its leads, is designed to let manufacturers share structured data once, from their own systems, rather than in a dozen copies. Connecting it to testing and certification bodies would be the step that matters most for safety, because it would let a reader trace a claim back to its evidence.
  2. Who owns the assembly? The law assigns responsibility, and contracts can make it specific. For each critical assembly, a named competent reviewer, appointed by and reporting to the client, should establish whether the evidence covers the proposed configuration, record the basis of acceptance and require a fresh review when a substitution changes that basis. None of this needs new legislation. It needs clients to ask for it, pay for it and give the reviewer authority to say no. Sometimes the better answer is to remove the choice, by constraining substitutions or buying a tested, manufactured assembly rather than a list of parts. Even then, someone must check where that assembly meets the rest of the building.
  3. Is the check actually made and made properly? Responsibility already sits with the designer and the contractor, and that is not new: principal designers and principal contractors carry legal duties to ensure that work complies. But a duty to check is not the same as knowing what to check, or how. A test report is only as useful as the reader’s grasp of what it left out: the substrate, the fixings, the cavity, the joint. Deciding whether a substitution falls outside it is a job for a specialist, not a form, and a passport helps only if it shows what each test covered

Addressing the last question is hard enough at the best of times. It is harder when margins are thin and every scheme is under pressure to value engineer its way to viability. Then it takes competence, care and a calm head, because the easy answer is the document that seems to say yes. Passports will certainly help but equally they will not answer any of them on their own. Our view is that any reform will turn on these questions, and they will decide whether product records make buildings safer or merely better documented. The UK, starting later than the EU, can design its records with them in mind. Starting behind can be a disadvantage, but starting with hindsight need not be.

A different solution

Britain did not solve the Triludan problem with a better label. It took the drug off the pharmacy shelf, and the market moved in a different direction.

For residential buildings over 18 metres, England has made a similar choice, effectively banning combustible materials from their external walls rather than relying on tests of whole systems. Where a choice can be removed, removing it is safer than relying on the right decision every time. Where it cannot, the passport will describe the parts with more precision than construction has ever managed.  But someone will still have to answer for the whole.

 

Jamie Hillier

Partner
Contact

With a penchant for tweed and jackets with leather arm patches, Jamie began his career as a quantity surveyor, before climbing the ladder to lead major projects for a Tier 1 contractor.

Eventually expanding his book collection beyond copies of SMM7, Jamie has interest in a broad range of subjects linked to delivering better outcomes for society and the environment.

His strategic insights on MMC and behavioural science have made their way into numerous government, industry and academic publications, including the Construction Playbook, Transforming Infrastructure Performance Roadmap to 2030, the Platform Rulebook and the RIBA DfMA Overlay.

John Handscomb

Partner
Contact

Construction is in John’s blood. Learning from his father who was a planner and project manager, John began his career by working on some iconic projects in both the public and private sector.

As a procurement expert and integrator of new ways of working, John has pioneered the integration of platform principles, DfMA processes and supply chain within over £5bn projects in the last 15 years, for some of the largest building programmes in the UK. Despite his considerable expertise, John keeps it simple, communicating complicated ideas with ease and helping to equip the industry with new knowledge and skills.

Outside of Akerlof, John enjoys his executive role with technology start-up ScanTech Digital, spending time with his family, taking trips down the football, playing a bit of golf with friends and the odd pint. 

Our name is shared with George Akerlof, a Nobel Prize-winning economist.

His seminal paper, Market for Lemons, demonstrated the devastating consequences of making decisions under the conditions of quality uncertainty and unequal information between buyers and sellers, increasing the chance of buyers ending up with a ‘lemon’.

This 50-year-old concept continues to retain parallels within the construction industry.

Through our insight and experience, we can rebalance this information asymmetry on behalf of our clients, levelling the playing field to deliver better outcomes.